Interferon-tau and progesterone regulate ubiquitin cross-reactive protein expression in the ovine uterus.
Ubiquitin cross-reactive protein (UCRP) is a functional ubiquitin homolog synthesized by the ruminant endometrium in response to conceptus-derived interferon-tau (IFNtau). Progesterone is required for IFNtau to exert antiluteolytic actions on the endometrium. Therefore, this study was designed to determine whether progesterone is requisite for IFNtau induction of UCRP expression within the ovine uterus. Cyclic ewes were ovariectomized and fitted with intrauterine (i.u.) catheters on Day 5 and treated daily with steroids (i.m.) and protein (i.u.) as follows: 1) progesterone (P, Days 5-24) and control serum proteins (CX, Days 11-24); 2) P and ZK 137.316 (ZK; progesterone receptor antagonist, Days 11-24) and CX proteins; 3) P and recombinant ovine IFNtau (roIFNtau, Days 11-24); or 4) P and ZK and roIFNtau. All ewes were hysterectomized on Day 25. In P-treated ewes, roIFNtau increased endometrial UCRP mRNA and protein levels. However, administration of ZK to ewes ablated roIFNtau induction of UCRP. Recombinant ovine IFNtau induced expression of UCRP mRNA in progestinized endometrial luminal (LE) and glandular (GE) epithelium as well as in both stratum compactum and spongiosum layers of the stroma (ST). Progesterone receptor protein was located in endometrial ST, but not in LE and GE from these ewes. Results support the hypothesis that progesterone is required for IFNtau induction of type I IFN-responsive genes, such as UCRP, in the ruminant uterus.
Johnson
G A
GA
Center for Animal Biotechnology, Texas A&M University, College Station, Texas 77843-2471, USA.
Spencer
T E
TE
Burghardt
R C
RC
Joyce
M M
MM
Bazer
F W
FW
D000818:Animals; D015153:Blotting, Western; D005260:Female; D006727:Hormone Antagonists / Q000494:pharmacology; D007044:Hysterectomy; D017403:In Situ Hybridization; D007370:Interferon Type I / Q000378:metabolism* / Q000494:pharmacology; D011257:Pregnancy Proteins / Q000378:metabolism* / Q000494:pharmacology; D011374:Progesterone / Q000037:antagonists & inhibitors / Q000378:metabolism* / Q000494:pharmacology; D012756:Sheep / Q000502:physiology; D014452:Ubiquitins / Q000031:analogs & derivatives* / Q000187:drug effects / Q000235:genetics / Q000378:metabolism; D014599:Uterus / Q000187:drug effects / Q000378:metabolism*
D006727:Hormone Antagonists; D007370:Interferon Type I; D011257:Pregnancy Proteins; D014452:Ubiquitins; C020947:interferon tau; D011374:Progesterone